부가기능
Improved Prevention of Moderately Emetogenic Chemotherapy-Induced Nausea and Vomiting with Palonosetron, a Pharmacologically Novel 5-HT~3 Receptor Antagonist: Results of a Phase III, Single-Dose Trial Versus Dolasetron/
기사 상세정보
서평
서평등록 중 오류가 발생하였습니다. 재시도 하십시오.